Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Sleep Quality and Oxidative Stress in Postoperative Cardiovascular Patients-A Pilot Study.

Journal of sleep research·2026
Same author

A Functional <i>HMOX2</i> Genetic Variant Is Associated with Resting Diastolic and Mean Arterial Pressure in Healthy Humans.

Antioxidants (Basel, Switzerland)·2026
Same author

Insomnia disorder.

Nature reviews. Disease primers·2026
Same author

Sleep-Related Attentional Bias in Insomnia: A Drift Diffusion Model Approach.

Journal of sleep research·2026
Same author

The effectiveness of Cognitive behavioral therapy for insomnia on sleep EEG hyperarousal: a multicentric polysomnographic study.

Translational psychiatry·2026
Same author

Efficacy and safety of chlorhexidine vs. povidone-iodine for vaginal antisepsis in surgery: an updated systematic review and meta-analysis.

Annals of medicine and surgery (2012)·2026
Same journal

Postmortem Evidence of CRH Neuron Reduction in Narcolepsy Without Cataplexy With Borderline Hypocretin-1 Levels.

Journal of sleep research·2026
Same journal

Continuous Positive Airway Pressure Versus Mandibular Advancement Devices Impact on Cardio-Metabolic Outcomes in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Journal of sleep research·2026
Same journal

Strong and Weak Episodic Memories Are Shaped by Multiple Cycles of NREM Spindles and REM Alpha Bursts.

Journal of sleep research·2026
Same journal

A Systematic Review and Meta-Analysis of Biological Sex Differences in Sleep Spindles and Slow Wave Activity in Adults With and Without Insomnia.

Journal of sleep research·2026
Same journal

Thoracoabdominal Asynchrony in Healthy Children.

Journal of sleep research·2026
Same journal

Chronotype and Time of Day Effects in Oddball Task Performance: Behavioural and Cerebral Correlates.

Journal of sleep research·2026
See all related articles
  1. Home
  3. Risks Associated With Benzodiazepine Long-term Use In Chronic Insomnia: A Systematic Review And (network) Meta-analysis.
  1. Home
  3. Risks Associated With Benzodiazepine Long-term Use In Chronic Insomnia: A Systematic Review And (network) Meta-analysis.

Related Experiment Video

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Risks Associated With Benzodiazepine Long-Term Use in Chronic Insomnia: A Systematic Review and (Network)

Dieter Riemann1, Chiara Baglioni1,2, Christoph Nissen3

  • 1Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Faculty of Medicine University of Freiburg, Freiburg, Germany.

Journal of Sleep Research
|June 11, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Long-term benzodiazepine use for chronic insomnia may worsen sleep quality and mental health. This review suggests prioritizing behavioral therapy and safer alternatives due to potential risks like increased depression and anxiety.

Keywords:
benzodiazepineschronic insomniainsomniameta‐analysissystematic review

More Related Videos

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
05:59

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Related Experiment Videos

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
05:59

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Area of Science:

  • Pharmacology
  • Sleep Medicine
  • Mental Health

Background:

  • Chronic insomnia significantly impacts daily functioning and quality of life.
  • Benzodiazepines are commonly prescribed for insomnia but carry risks with prolonged use.
  • Concerns include dependence, side effects, and long-term health implications.

Purpose of the Study:

  • To systematically review the risks associated with benzodiazepine use exceeding 3 months in adults with chronic insomnia.
  • To evaluate the impact on sleep quality, safety, mental health, and overall quality of life.
  • To synthesize evidence from studies published between 1987 and 2023.

Main Methods:

  • Systematic literature review of 27 studies.
  • Included adults with insomnia symptoms lasting at least 3 months.
  • Meta-analysis of outcomes: insomnia severity, sleep quality, falls, depression, and anxiety.

    • Main Results:

    • Benzodiazepine users had more severe insomnia than healthy sleepers but less than non-medicated individuals.
    • No significant difference in the risk of falls between benzodiazepine users and non-users.
    • Benzodiazepine users reported significantly higher depression and anxiety levels compared to healthy sleepers.

    Conclusions:

    • Extended benzodiazepine use may negatively affect sleep quality, mental health, and quality of life.
    • Evidence on long-term benzodiazepine use is limited.
    • Findings support guidelines for limited use and suggest prioritizing behavioral therapy and safer pharmacotherapies.